Published on in Vol 10 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/46893, first published
.
Evaluating the Usefulness and Ease of Use of a Next-Generation–Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals’ Perceptions
Evaluating the Usefulness and Ease of Use of a Next-Generation–Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals’ Perceptions
Journals
- van Dommelen P, Arnaud L, Assefi A, Crespo M, Debicki M, Michelis F, Koledova E. The growzen™ buddy smartphone app to improve adherence in patients receiving recombinant human growth hormone therapy: a retrospective observational study in Argentina. Frontiers in Endocrinology 2024;15 View
- Rivera Romero O, Chae H, Faienza M, Vergani E, Cheon C, Di Mase R, Frasca F, Lee H, Giavoli C, Kim J, Klain A, Moon J, Iezzi M, Yeh J, Aversa A, Rhie Y, Koledova E. Healthcare professionals’ perspectives towards the digitalisation of paediatric growth hormone therapies: expert panels in Italy and Korea. Frontiers in Endocrinology 2024;15 View
- de Arriba A, van Dommelen P, Savage M. Use of connected injection device has a positive effect on catch-up growth in patients with growth disorders treated with growth hormone therapy. Frontiers in Endocrinology 2024;15 View
- Dimitri P, van Dommelen P, Banerjee I, Bellazzi R, Ciaccio M, de Arriba Muñoz A, Loche S, Zaini A, Halabi A, Bagha M, Koledova E. Opportunities for digitally-enabled personalization and decision support for pediatric growth hormone therapy. Frontiers in Endocrinology 2024;15 View